Company profile: 3P Biopharmaceuticals
1.1 - Company Overview
Company description
- Provider of biologics and cell therapy development and manufacturing services. Offers comprehensive CDMO support, including process and analytical development, preclinical and clinical supply, and commercial production. Produces proteins via mammalian (CHO, NS0, BHK-21, HEK293, Hybridoma) and microbial (E. coli, P. pastoris, S. cerevisiae, H. pylori, S. noursei) systems, and provides cell therapy technology transfer, process development, cell culture, and GMP certification.
Products and services
- Biologics CDMO Services: Delivers industrial-grade development and manufacturing of biologics, spanning process and analytical development, preclinical and clinical supply, and commercial production
- Cell Therapy Services: Architects GMP-certified pathways for cell therapy product development and manufacturing, covering technology transfer, process development, robust cell culture operations, and formal GMP certification support
- Mammalian Services: Produces custom-engineered proteins using CHO, NS0, BHK-21, HEK293, and Hybridoma cell lines, offering flexibility and experience to meet varied project needs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to 3P Biopharmaceuticals
Pharmalog
HQ: Germany
Website
- Description: Provider of clinical research services as a clinical research organization, conducting Phase I and Phase II–IV trials for pharmaceutical and biotechnology companies, as well as non-interventional (NIS) studies. Offers research programs, special trials including dermatological/cosmetic studies, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmalog company profile →
Pyramid Laboratories
HQ: United States
Website
- Description: Provider of contract parenteral drug product manufacturing and analytical services for the pharmaceutical and biotechnology industries, including aseptic vial and syringe filling, lyophilization, formulation and process development, clinical supply manufacturing, commercial fill/finish, and labeling, storage, and global distribution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyramid Laboratories company profile →
ShangPharma Innovation
HQ: United States
Website
- Description: Provider of global innovation incubation and investment focused on biomedical R&D technologies and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ShangPharma Innovation company profile →
Casimir
HQ: United States
Website
- Description: Provider of virtual trials and remote assessments and qualitative research centered on the patient experience, capturing the real-world impact of treatment interventions on patient quality-of-life through smart outcome measures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Casimir company profile →
ZenBio
HQ: United States
Website
- Description: Provider of human cell-based research products and contract research services, including preadipocytes and adipocytes for drug screening and development; cell-based assay development and custom consultations; individualized cell-based or biochemical screening programs; cell characterization and molecular biology services; and ready-to-use visceral preadipocyte and adipocyte media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZenBio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for 3P Biopharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to 3P Biopharmaceuticals
2.2 - Growth funds investing in similar companies to 3P Biopharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for 3P Biopharmaceuticals
4.2 - Public trading comparable groups for 3P Biopharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →